Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study

Objective: To evaluate the safety and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in gynecologic oncology patients under chemotherapy. Methods: A prospective cohort study including gynecologic oncology women who were under chemotherapy or had completed it within 6 months at the time of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Palaia, Innocenza, Caruso, Giuseppe, Di Donato, Violante, Vestri, Annarita, Napoli, Anna, Perniola, Giorgia, Casinelli, Matteo, Alunni Fegatelli, Danilo, Campagna, Roberta, Tomao, Federica, D’Aniello, Debora, Antonelli, Guido, Muzii, Ludovico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780883/
https://www.ncbi.nlm.nih.gov/pubmed/35062673
http://dx.doi.org/10.3390/vaccines10010012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780883/
https://www.ncbi.nlm.nih.gov/pubmed/35062673
http://dx.doi.org/10.3390/vaccines10010012

Ejemplares similares